Mucus hypersecretion in chronic obstructive pulmonary disease

Novartis Foundation Symposium

Volumn 234, Issue , 2001, Pages 65-83

  Rogers, Duncan F ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN;

CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; METABOLISM; MUCUS; REVIEW; SECRETION;

HUMANS; LUNG DISEASES, OBSTRUCTIVE; MUCINS; MUCUS;

EID: 0035218725     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (38)

1. Aikawa T, Shimura S, Sasaki H, Takashima T, Yaegashi H, Takahashi T 1989 Morphometric analysis of intraluminal mucus in airways in chronic obstructive pulmonary disease. Am Rev Respir Dis 140:477-482
2. American Thoracic Society 1962 Definitions and classification of chronic bronchitis, asthma, and pulmonary emphysema. Am Rev Respir Dis 85:762-768
3. American Thoracic Society 1995 Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (suppl) 152:S77-S121
4. Annesi I, Kauffmann F 1986 Is respiratory mucus hypersecretion really an innocent disorder? A 22-year study mortality study of 1061 working men. Am Rev Respir Dis 134:688-693
5. British Thoracic Society 1997 BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of care of the BTS. Thorax (suppl 5) 52:S1-S28
6. Canadian Thoracic Society Workshop Group 1992 Guidelines for the assessment and management of chronic obstructive pulmonary disease. Can Med Assoc J 147:420-428
7. Ciba Guest Symposium 1959 Terminology, definitions, and classification of chronic pulmonary emphysema and related conditions. Thorax 14:286-299
8. Ebi-Kryston KL 1988 Respiratory symptoms and pulmonary function a predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall study. J Clin Epidemiol 41:251-260
9. Fletcher C, Peto R 1977 The natural history of chronic airflow obstruction. Br Med J 1:1645-1648
10. Fletcher CM, Pride NB 1984 Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Ciba symposium. Thorax 39:81-85
11. Hayes JA 1969 Distribution of bronchial gland measurements in a Jamaican population. Thorax 24:619-622
12. Higgins MW, Keller JB, Becker M et al 1982 An index of risk for obstructive airways disease. Am Rev Respir Dis 125:144-151
13. Hogg JC, Macklem PT, Thurlbeck WM 1968 Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 278:1355-1360
14. Hovenberg HW, Davies JR, Herrman A, Lindén C-J, Carlstedt I 1996 MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions. Glycoconj J 13:839-847
15. Jeffery PK, Li D 1997 Airway mucosa: secretory cells, mucus and mucin genes. Eur Respir J 10:1655-1662
16. Jenkins C, Mitchell C, Irving L, Frith P, Young I, for Thoracic Society of Australia and New Zealand 1995 Guidelines for the management of chronic obstructive pulmonary disease. Mod Med Australia 38:132-146
17. Kauffmann F, Drouet D, Lellouch J, Brille D 1979 Twelve years spirometric changes among Paris area workers. Int J Epidemiol 8:201-212
18. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P 1990 Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 45:579-585
19. Medical Research Council 1965 Definition and classification of chronic bronchitis for clinical and epidemiological purposes. Lancet i:775-779
20. Nightingale JA, Rogers DF 2000 Should drugs affecting mucus properties be used in COPD? Clinical evidence. In: Similowski T, Whitelaw W, Derenne J-P (eds) Clinical management of stable COPD. Marcel Dekker, New York, in press
21. Peto R, Speizer FE, Cochrane AL et al 1983 The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis 128:491-500
22. Poole PJ, Black PN 1999 Mucolytic agents for chronic bronchitis (Cochrane Review). In: The Cochrane Library, Issue 2. Oxford: Update Software
23. Reid L 1954 Pathology of chronic bronchitis. Lancet i:275-278
24. Reid L 1960 Measurement of the bronchial mucous gland layer: a diagnostic yardstick in chronic bronchitis. Thorax 15:132-141
25. Restrepo G, Heard BE 1963 The size of the bronchial glands in chronic bronchitis. J Pathol Bacteriol 85:305-310
26. Rogers DF 1994 Airway goblet cells: responsive and adaptable front-line defenders. Eur Respir J 7:1690-1706
27. Rose MG, Gendler SJ 1997 Airway mucin genes and gene products. In: Rogers DF, Lethem MI (eds) Airway mucus: basic mechanisms and clinical perspectives. Birkhäuser Verlag, Basel, p 41-66
28. Siafakas NM, Vermiere P, Pride NB et al 1995 Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Taskforce. Eur Respir J 8:1398-1420
29. Sherman CB, Xu X, Speizer FE, Ferris BG Jr, Weiss ST, Dockery DW 1992 Longitudinal lung function decline in subjects with respiratory symptoms. Am Rev Respir Dis 146:855-859
30. Snider GL, Faling LJ, Rennard SI 1994 Chronic bronchitis and emphysema. In: Murray JF, Nadel JA (eds) Textbook of respiratory medicine. WB Saunders, Philadelphia, PA, p 1331-1397
31. Speizer FE, Fay ME, Dockery DW, Ferris BG Jr 1989 Chronic obstructive pulmonary disease mortality in six US cities. Am Rev Respir Dis 140:S49-S55
32. Steiger D, Fahy J, Boushey H, Finkbeiner WE, Basbaum C 1994 Use of mucin antibodies and cDNA probes to quantify hypersecretion in vivo in human airways. Am J Respir Cell Mol Biol 10:538-545
33. Thornton DJ, Davies JR, Carlstedt I, Sheehan JK 1997 Structure and biochemistry of human respiratory mucins In: Rogers DF, Lethem MI (eds) Airway mucus: basic mechanisms and clinical perspectives. Birkhäuser Verlag, Basel, p 19-39
34. Thurlbeck WM, Angus GE 1964 A distribution curve for chronic bronchitis. Thorax 19:436-442
35. Thurlbeck WM, Angus GE, Paré JAP 1963 Mucous gland hypertrophy in chronic bronchitis, and its occurrence in smokers. Br J Dis Chest 57:73-78
36. Vestbo J, Prescott E, Lange P 1996 Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 153:1530-1535
37. Widdicombe JG 1990 A critical look at mucus markers. In: Persson CGA, Brattsand R, Laitinen LA (eds) Inflammatory indices of chronic bronchitis. Birkhäuser Verlag, Basel, p 269-279
38. Widdicombe JH, Widdicombe JG 1994 Regulation of human airway surface liquid. Respir Physiol 99:3-12